EFFECT OF IMMUNOCHEMOTHERAPY ON LYMPHOCYTE-RESPONSE OF PATIENTS WITH GASTRO-INTESTINAL CANCER

被引：5

作者：

MASHIBA, H ^{[1
]}

YOSHINAGA, H ^{[1
]}

MATSUNAGA, K ^{[1
]}

GOJOBORI, M ^{[1
]}

FURUSAWA, M ^{[1
]}

机构：

[1] KYUSHU CANC CTR HOSP,DEPT GASTROINTESTINAL SURG,FUKUOKA,JAPAN

来源：

JOURNAL OF SURGICAL ONCOLOGY | 1979年 / 12卷 / 03期

关键词：

gastrointestinal cancer; host response; immunochemotherapy;

D O I：

10.1002/jso.2930120312

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with gastrointestinal cancer were treated with 5‐fluorouracil (5‐FU) in combination with a streptococcal preparation, OK‐432, or without OK‐432 before operation, and lymphocyte response to PHA was examined. Oral administration of 5‐FU with or without intramuscular injection of OK‐432 did not affect the response. However, treatment with cytostatic drugs in combination with OK‐432 markedly augmented the lymphocyte response to PHA, but the cytotoxic activity of lymphocytes was not elevated. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company

引用

页码：275 / 279

页数：5

共 14 条

[1] New approaches to the treatment of gastro-intestinal cancer
Waters, JS
Ross, PJ
Popescu, RA
Cunningham, D
DIGESTION, 1997, 58 (06) : 508 - 519
[2] Micronutrient Food Supplements in Patients with Gastro-Intestinal and Hepatic Cancers
Alam, Waqas
Ullah, Hammad
Santarcangelo, Cristina
Di Minno, Alessandro
Khan, Haroon
Daglia, Maria
Arciola, Carla Renata
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
[3] Detection and clinical implications of minimal residual disease in gastro-intestinal cancer
Fabian Wolfrum
Ilka Vogel
Fred Fändrich
Holger Kalthoff
Langenbeck's Archives of Surgery, 2005, 390 : 430 - 441
[4] Detection and clinical implications of minimal residual disease in gastro-intestinal cancer
Wolfrum, F
Vogel, I
Fändrich, F
Kalthoff, H
LANGENBECKS ARCHIVES OF SURGERY, 2005, 390 (05) : 430 - 441
[5] Iron Surveillance and Management in Gastro-Intestinal Oncology Patients: A National Physician Survey
Richard, Emilie S.
Hrycyshyn, Adriyan
Salman, Noor
Remtulla Tharani, Alliya
Abbruzzino, Alexandria
Smith, Janet
Kachura, Jacob J.
Sholzberg, Michelle
Mosko, Jeffrey D.
Chadi, Sami A.
Burkes, Ronald L.
Pankiw, Maya
Brezden-Masley, Christine
CURRENT ONCOLOGY, 2023, 30 (11) : 9836 - 9848
[6] SOME ASPECTS OF SOCIAL AND WORKING REHABILITATION OF PATIENTS WITH GASTRO-INTESTINAL TUMORS AFTER RADICAL OPERATIONS
SIMONOV, NN
GNEZDILOV, AV
BERJOZKIN, DP
MEDICAL AND PEDIATRIC ONCOLOGY, 1979, 7 (02): : 103 - 109
[7] Tumor M2-pyruvate kinase: A promising tumor marker in the diagnosis of gastro-intestinal cancer
Hardt, PD
Ngoumou, BK
Rupp, J
Schnell-Kretschmer, H
Kloer, HU
ANTICANCER RESEARCH, 2000, 20 (6D) : 4965 - 4968
[8] Thymine as potential biomarker to predict 5-FU systemic exposure in patients with gastro-intestinal cancer: a prospective pharmacokinetic study (FUUT-trial)
Hanrath, Maarten A.
Banken, Evi
van den Wildenberg, Sebastian A. H.
van de Kerkhof, Daan
Moes, Dirk Jan A. R.
Boisdron-Celle, Michele
van den Bosch, Bianca J. C.
Bax, Ramon
Bet, Pierre M.
Maring, Jan Gerard
Creemers, Geert-Jan M.
van Hellemond, Irene. E. G.
Deenen, Maarten J.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
[9] Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial
Roberto, Michela
Romiti, Adriana
Mazzuca, Federica
Milano, Annalisa
D'Antonio, Chiara
Lionetto, Luana
Falcone, Rosa
Strigari, Lidia
Simmaco, Maurizio
Fais, Stefano
Marchetti, Paolo
CANCERS, 2020, 12 (11) : 1 - 12
[10] Alterations in Peripheral Lymphocyte Subsets under Immunochemotherapy in Stage IV SCLC Patients: Th17 Cells as Potential Early Predictive Biomarker for Response
Schmaelter, Ann-Kristin
Loehr, Phillip
Konrad, Maik
Waidhauser, Johanna
Arndt, Tim Tobias
Schiele, Stefan
Thoma, Alicia
Hackanson, Bjoern
Rank, Andreas
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)

← 1 2 →